Logo image
Evaluating the use of lamotrigine to reduce mood lability and impulsive behaviors in adults with chronic and severe eating disorders
Journal article   Open access   Peer reviewed

Evaluating the use of lamotrigine to reduce mood lability and impulsive behaviors in adults with chronic and severe eating disorders

Erin E. Reilly, Laura A. Berner, Mary Ellen Trunko, Terry Schwartz, Leslie K. Anderson, Angeline Krueger, Xinze Yu, Joanna Y. Chen, Anne Cusack, Tiffany Nakamura, …
Eating and weight disorders, v 27(5), pp 1775-1785
01 Jun 2022
PMID: 35298791
url
https://link.springer.com/content/pdf/10.1007/s40519-021-01320-3.pdfView
Published, Version of Record (VoR) Open
url
https://doi.org/10.1007/s40519-021-01320-3View
Published, Version of Record (VoR) Open

Abstract

Life Sciences & Biomedicine Psychiatry Science & Technology
Background Gold-standard psychological and pharmacological treatments for bulimic-spectrum eating disorders only result in remission for around 50% of patients; patients with affective lability and impulsivity represent a subgroup with particularly poor outcomes. Both dialectical behavior therapy (DBT), a treatment for emotion dysregulation, and lamotrigine, a mood stabilizer, have demonstrated promise for targeting affective lability and impulsivity; however, data exploring the combination of these interventions remain limited. Objective We followed a group of women with recurrent dysregulated eating behaviors (N = 62) throughout intensive DBT treatment and compared the symptom trajectory of those prescribed lamotrigine (n = 28) and those who were not (n = 34). Method Participants completed surveys every 2 weeks throughout treatment. Results Group analyses suggested that all participants self-reported decreases in emotional reactivity, negative urgency, and symptoms of borderline personality disorder (BPD). The lamotrigine group reported greater elevations in BPD symptoms at baseline, but demonstrated steeper decreases in emotion and behavioral dysregulation than the non-matched comparison group. Within-subject analyses suggested that within the lamotrigine group, subjects reported greater decreases in symptoms following prescription of lamotrigine. Conclusions Findings provide initial data suggesting that lamotrigine could be useful as an adjunctive treatment for patients with affective lability and impulsivity.

Metrics

19 Record Views
8 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being
#5 Gender Equality

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Psychiatry
Logo image